BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Zhou H, Su Y. Targeting truncated RXRα for cancer therapy. Acta Biochim Biophys Sin (Shanghai) 2016;48:49-59. [PMID: 26494413 DOI: 10.1093/abbs/gmv104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zeng D, Zhang L, Luo Q. Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro. Front Pharmacol 2023;14:1124240. [PMID: 36874033 DOI: 10.3389/fphar.2023.1124240] [Reference Citation Analysis]
2 Shao J, Bernicker EH, He C, Li Z. Cell‐free DNA 5‐hydroxymethylcytosine as a marker for common cancer detection. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.136] [Reference Citation Analysis]
3 Wang Q, Tu X, Wang X, Cai Q, Yu L, Zhang X, Yi J, Wu Y, Xie G, Yuan H, Li M, Zhang X, Zeng Z, Su Y. Design, synthesis and biological evaluation of acyl hydrazones-based derivatives as RXRα-targeted anti-mitotic agents. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.106069] [Reference Citation Analysis]
4 Li F, Song C, Zhang Y, Wu D. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs. Acta Biochim Biophys Sin (Shanghai) 2022;54:12-24. [PMID: 35130630 DOI: 10.3724/abbs.2021001] [Reference Citation Analysis]
5 Sołtys K, Leszczyński B, Ożyhar A. RXR – centralny regulator wielu ścieżek sygnałowych w organizmie. Postępy Higieny i Medycyny Doświadczalnej 2021;75:511-28. [DOI: 10.2478/ahem-2021-0005] [Reference Citation Analysis]
6 Ye X, Wu H, Sheng L, Liu YX, Ye F, Wang M, Zhou H, Su Y, Zhang XK. Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling. Nat Commun 2019;10:1463. [PMID: 30931933 DOI: 10.1038/s41467-019-09375-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
7 Wang X, Chong S, Lin H, Yan Z, Huang F, Zeng Z, Zhang X, Su Y. Discovery of atorvastatin as a tetramer stabilizer of nuclear receptor RXRα through structure-based virtual screening. Bioorg Chem 2019;85:413-9. [PMID: 30665035 DOI: 10.1016/j.bioorg.2019.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ren G, Bao W, Zeng Z, Zhang W, Shang C, Wang M, Su Y, Zhang XK, Zhou H. Retinoid X Receptor Alpha Nitro-ligand Z-10 and Its Optimized Derivative Z-36 Reduce β-Amyloid Plaques in Alzheimer's Disease Mouse Model. Mol Pharm 2019;16:480-8. [PMID: 29995422 DOI: 10.1021/acs.molpharmaceut.8b00096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chen L, Wu L, Zhu L, Zhao Y. Overview of the structure-based non-genomic effects of the nuclear receptor RXRα. Cell Mol Biol Lett 2018;23:36. [PMID: 30093910 DOI: 10.1186/s11658-018-0103-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Shi WN, Cui SX, Song ZY, Wang SQ, Sun SY, Yu XF, Li Y, Zhang YH, Gao ZH, Qu XJ. Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXRα by K48/K63-linked polyubiquitination. Oncotarget 2017;8:39605-17. [PMID: 28465486 DOI: 10.18632/oncotarget.17174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]